Clinical trial · Interventional
Serum Trace Element Levels in Some Gynecological Diseases
Serum Trace Element Profiles in Women With Endometriosis, Ovarian and Endometrial Cancer: An ICP-MS-Based Comparative Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this clinical study is to measure the levels of various trace elements in the blood serum of women with various gynecological diseases and to compare them with healthy controls. The main questions it aims to answer are: * Do trace element levels increase or decrease in endometriosis? * Do trace element levels increase or decrease in ovarian cancer patients? * Do trace element levels increase or decrease in endometrial cancer patients? Participants: Each member of the study group will visit the clinic only once and donate 5 ml of blood.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
| Endometriosis | — | UNRESOLVED | — |
| Healthy Control | — | UNRESOLVED | — |
| Over Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood Product | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- Control group
- description
- Consists of healthy individuals
- interventionNames
- Diagnostic Test: Blood Product
- type
- EXPERIMENTAL
- label
- Endometriosis group
- description
- Consists of individuals diagnosed with endometriosis
- interventionNames
- Diagnostic Test: Blood Product
- type
- EXPERIMENTAL
- label
- Overian cancer group
- description
- Consists of individuals diagnosed with ovarian cancer
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 55 Years
Show eligibility criteria text
Inclusion Criteria: * Not having received chemotherapy, radiotherapy or immunotherapy in the last three months * For the endometriosis group: histopathologically or laparoscopically confirmed endometriosis * For the ovarian cancer group: histopathologically confirmed epithelial ovarian cancer * For the endometrial cancer group: histopathologically confirmed endometrial adenocarcinoma * For the control group: healthy individuals who underwent surgery for benign gynecological causes (e.g., myoma, benign cyst) and who were not diagnosed with malignancy/endometriosis Exclusion Criteria: * Chronic systemic diseases (e.g., chronic renal failure, liver disease, severe cardiac disease) * Diseases that may affect metabolism or trace element levels (e.g., Wilson's disease, hemochromatosis) * Use of dietary supplements containing minerals or trace elements within the past 6 months * Environmental or occupational heavy metal exposure (e.g., mining, metallurgy, battery industry workers) * Pregnancy or breastfeeding * History of acute infection or inflammatory disease * History of recurrent surgery or advanced metastatic cancer (as this may alter serum parameters) * Psychiatric or cognitive disorders that preclude participation in the study
References
Publications (0)
Data not yet available